Petragen
Davie, US · Founded 2020 · Delaware corporation
Founders & leadership
DK
David KolbCEO and President
DB
Demetrios Braddock, MD, PhDNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.4M disclosed across 2 rounds · 2021–2026
▶$495KraisedJun 2026 · 9 investors · BiotechnologyRule 506(b)
▶$495KraisedJun 2026 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Demetrios Braddock, MD, PhDExecutive Officer
- David KolbExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $495K
- Sales commissions
- $100K
- Placement agents
- Bradley Woods & Co. Ltd.
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedFeb 2022 · 39 investors · BiotechnologyRule 506(b)
▶$1.9MraisedFeb 2022 · 39 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Demetrios Braddock, MD, PhDPromoter
- David KolbExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $1.9M
- Sales commissions
- $109.7K
- Placement agents
- Bradley Woods Ltd.
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Petragen raised?
- Petragen has disclosed $2.4M raised across 2 rounds.
- Where is Petragen headquartered?
- Petragen is headquartered in Davie, US.